Great success of the EuCARE meeting in Lisbon
15-16 September 2022, Lisbon
Representatives of all project partners from Europe and Brazil gathered in the Portuguese capital to share the results obtained in the first eleven months of the project and to decide how to face future challenges.
Hosted by the Instituto de Higiene e Medicina Tropical, in an atmosphere of excellent collaboration, everyone actively participated in the plenary session and especially in the parallel sessions that allowed a more focused discussion and analysis of the project's activities.
Coordinated by EuResist Network, EuCARE will start its second year of activity in October in a completely changed context. Achieving the project's scientific objectives by adapting to the continuous changes of the epidemics is the challenge that the whole consortium has accepted with enthusiasm. We look forward to seeing each other again but for the moment a special thanks to the entire organizational team and to all the participants who made this meeting particularly fruitful both from a scientific and a human point of view.
EuCARE Scientific Board Meeting in Lisbon
15-16 September 2022, Lisbon
After almost one year of online meetings, the EuCARE project Consortium meets again in Lisbon on 15 and 16 September.
Hosted by the Instituto de Higiene e Medicina Tropical - Universidade NOVA de Lisboa, in the presence of our distinguished Scientific and Ethics external Boards and EC Project officer Patricia Urban-Lopez, representatives of all the EuCARE beneficiaries will participate in the two-day meeting with the aim of sharing what has been done so far and planning the next activities in light of the progress of the pandemic.
We are all very happy to have an opportunity to exchange our ideas in the presence once again: certainly the best way to achieve the results we expect.
EuCARE workshop at the 22nd Arevir- EuResist Meeting
06-07 May 2022, Cologne
The workshop on COVID-19 organised within the 22nd Arevir-EuResist Meeting will be focused on EUCARE as a European-project for the investigation of SARS-CoV-2 and epidemics.
Chaired by Francesca Incardona (EuResist) who coordinates the project, Maurizio Zazzi (Università di Siena) and Anders Sönnerborg (Karolinska Institutet), this session will see the participation of Mr. Jan Paehler, EC RTD, Policy Officer. The EuCARE Management Board Members will present the results already achieved in the first six months of the project and the next steps.
The 22nd Arevir- EuResist Meeting (Cologne, 06-07 May 2022) will also cover a broad range of current topics on viral resistance research pertaining to multiple pathogens such as HIV, HCV, HBV and M. Tuberculi.
Published on HIV Medicine the INTEGRATE experienced study
24 February 2022
The article "Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe" is now published online. Results from a cohort of over 13.000 INSTI experienced individuals in Europe.
Thanks to all the INTEGRATE working group!
Best Poster Award
27-30 October 2021, London
The Poster "Declining incidence of HIV multidrug resistance in Europe" has won the Best Poster Award at the 18th European AIDS Conference held Online & London, United Kingdom on October 27–30, 2021.
EuCARE Kick-off meeting
11-12 November 2021, Rome
We have been pleased to host in Rome the kick-off meeting of the project EuCARE European Cohorts of Patients and Schools to Advance Response to Epidemics funded by the EC under HORIZON-HLTH-2021-CORONA-01
Coordinated by Euresist Network, 22 primary universities, hospitals and ICT research centres are already working to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society.
CARE HIV-TB-HCV: EU-Russia cooperation results
15 June 2021, 9:00 – 16:00, Online conference
The online meeting organised by the CARE Consortium had the objective to present and discuss outcomes and findings from CARE Common Action and other projects and initiatives in the frame of recent collaborative research in the WHO European Region.
It has seen the participation of CARE, ARREST-TB, CARE External Scientific Advisory Board, CARE External Ethics Review Board, Russian experts, NDPHS, Russian Ministry of Health, Russian Ministry of Science and Higher Education, EC, EU Delegation to the Russian Federation.
Webinar "COVID-19 and variants: is it possible to re-open the schools?"
1 April 2021 https://vimeo.com/event/832587
The marginal role of schools as a center for spreading the infection, when the necessary containment measures are adopted, is now demonstrated by most of the scientific literature. However, doubts remain in society and in the political world, especially as regards high schools and relatively to the spread of viral variants.
On the contrary, the costs of closure are not yet fully known and are still likely to be underestimated.
The webinar sponsored by EuResist Network will support the scientific discussion on these themes while involving both the civil society and the political institutions.
With the participation of scientists as Antonella D'arminio Monforte, Sara Gandini, Daniele Novara, of associations as Save the Children, AcrionAid, ForumDD, of members of the Italian Parliament and of the Minister for Equal Opportunities and the Family Elena Bonetti.
Held with success the conference on “Joint efforts against infectious diseases: HIV, TB, HCV”
27 January 2020, Moscow
Held with success the high level conference in Moscow at the presence of the EU ambassador in Russia Mr Ederer, of the First Deputy Minister of the Ministry of Science and Higher Education of the Russian Federation Mr Trubnikov, and of the high representative of the Ministry of Health of the Russian Federation Mr Kostennikov,
The CARE and the ARREST-TB projects presented their interim results and fuelled a lively scientific discussion in a cooperative atmosphere.
EuResist Network is accepted as member of the UN Global Compact!
EuResist Network joins the UN Global Compact, the world's largest corporate initiative based on CEO commitments to implement universal sustainability principles and to take steps to support UN goals. See the Italian participants.
PhD fellowship on HIV molecular epidemiology
A PhD fellowship on HIV molecular epidemiology has been funded by the EuResist Network at the PhD programme in Data Science of Sapienza University of Rome. The PhD in Data Science of Sapienza is a multidisciplinary doctoral program coordinated by the Department of Computer, Control and Management Engineering "Antonio Ruberti".
The student supported by the fellowship, who has already been selected, will focus on epidemiology of subtype A in the EuResist Integrated DataBase.
The CARE project publishes its first results
In only ten months of activity the CARE partners created a solid ethics permissions, data and samples sharing infrastructure for a wide network of collaboration against HIV, TB and HCV. Already three papers have been published on HIV-1 resistance and epidemiology and the poster "HIV-1 A6 Subtype: its challenging identification and Southern Russian molecular epidemiology" (S. Sierra et al.) will be presented at EACS 2019!
The CARE project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825673.
Data from over 103, 000 HIV patients in EIDB
The EIDB, expanded to collect clinical and resistance information, contains now data from over 103, 000 HIV patients, The DB is always available for HIV research studies, subject to approval by the Scientific Board. If you are interested to submit a study please contact us.
Two posters from the EuResist Mentor School to be presented at EACS 2019
The two studies: “A retrospective analysis of the EuResist data set assessing dual therapy success in a real-life context” and “A retrospective analysis of the EuResist data set assessing if NRTI resistance impairs INSTI based treatment with NRTI backbone” have been realized by the participants of the EMS 2018 under guidance of the trainer M. Bohm and of EuResist Network mentors.
The project has been supported by Janssen Parmaceutical and Gilead Sciences.
INTEGRATE at EACS 2019
The INTEGRATE project results will be presented at. EACS 2019, to be held in Basel on November 6-9 2019, with an oral talk entitled "Prevalence of InSTI resistance and effectiveness of InSTI based regimens in HIV infected patients: results from a European cohort" (B. Brossetti et al.). The presentation will take place on Thursday, November 7th 2019 during the session "Basic and translational HIV biology" (14:00-16:00).
The project has been supported by an unrestricted grant from Gilead Sciences.
EuResist at the PROHIV 2019 international conference on HIV and AIDS, Moscow 23-24 September 2019
EuResist will be present with a talk entitled "The EuResist Integrated DataBase: how to exploit real life data for the study of HIV drug resistance" at the PROHIV 2019 international conference on HIV and AIDS to be held in Moscow on September 23-24 2019.
Two abstracts from the EMS at the 17th European Meeting on HIV & Hepatitis May 2019
Two studies realised by the students of the EuResist Mentor School under the guidance of the tutors will be presented as posters at the European HIV & Hep Meeting in Rome 22-24 May 2019.
EuResist at the AREVIR meeting 3-4 May 2019
EuResist recent results will be presented in the EuResist session within the annual AREVIR meeting in Cologne 3-4 May 2019.
The CARE project breakes the news
Read it on Il Sole 24 ore sanità!
CARE project kick-off meeting 23-24 January
The CARE project kick-off meeting will be in Rome on 23-24 January
Abstract on INTEGRATE dataset accepted at CROI 2019
The study on "GSS of NRTI-backbone predicts time to virological failure of InSTIs-based regimens" realised on INTEGRATE data has been accepted for poster presentation at CROI 2019
in Seattle 4-7 March 2019.
CARE project accepted for funding by the EC under the topic H2020-SC1-BHC-21-2018 of the H2020 programme
CARE is a COMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPE, coordinated by EuResist Network with scientific coordination of CHIP/RegionH
The on-site part of the novel training initiative by EuResist Network has been held in Cologne involving 30 students, on 3 May 2018.
EuResist at the AREVIR meeting 4-5 May 2018
EuResist recent results will be presented in the EuResist session within the annual AREVIR meeting in Cologne 4, 5 May 2018.
The study "Factorial HMM with Collapsed Gibbs Sampling for optimizing long-term HIV Therapy", realised on the EIDB has been accepted for presentation at the conference.
The EuResist Mentor School (EMS) is a training programme addressed to young virologists and clinicians to learn the basics of database querying (query scientific analysis, SQL language and statistics). Consult the programme and find the instructions on how to apply to participate here.
The study on II line resistance carried out by EuResist and its African partners has been presented as a poster at the XXVI international workshop on HIV drug resistance and treatment strategies, held on 6-8 November in Johannesburg.
EuResist at the EACS 2017 with 5 posters
25-27 October 2017
18 August 2017
Bioinformatics has accepted the manuscript: "PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context, P. Liebin et al. The PhyloGeoTool has been realised in the frame of the EucoHIV project.
The study on II line resistance carried out by EuResist and its African partners has been accepted at the XXVI international workshop on HIV drug resistance and treatment strategies that will be held on 6-8 November in Johannesburg.
Yaounde, Cameroon - 6-8 July 2017
The collaboration with CIRCB, University of Tor Vergata and I-PRO has started in the frame of the National workshop on "HIV test and treat strategy in Cameroon". The project is finalised to the realisation of a DHIS2 HIV resistance DB for Cameroon.
12-14 June 2017
Three abstracts from the AMS experience have been accepted at ICAR for oral presentations. This brings to 6 the number of abstracts accepted at national/international conferences coming from the work performed at AMS2016.
The EIDB has been updated. It now contains data of more than 81.000 patients. The EIDB is open for scientific studies under approval by the Scientific Board.
7 - 9 June 2017
5 - 6 May 2017
Thanks to the funding by Gilead Sciences Europe, the INTEGRATE project can take off. The project, devoted to the collection and analysis of clinical and virological data related to the use of INSTIs, will start with collection of data from the EuResist partners and will then widen the data collection.
Oslo, Norway - Feb 2017 - DHIS2 community, coordinated by the Department of Informatics at the University of Oslo selected as the User Story of the month the KRG-DHIS Pilot project, funded by the Italian Ministry of Foreign Affairs and International Cooperation, led by the University of Rome Tor Vergata in cooperation with the Ministry of Health of the Kurdistan Regional Government, and realized by I-PRO and EuResist Network.
6 Jan 2017
BMC infectious diseases has published our paper on HIV-1C epidemic in Ethiopia, using data collected starting from our EDCTP project
Moscow, 11-13 October 2016
EuResist participates in the II RCLM where EuResist partner Prof. Bobkova is organizer of the Virology section.
Seattle, 2-7 October 2016
A novel engine predicting time to HIV rebound as been presented at ACM conference on Bioinformatics and Computational Biology, oral presentation.
Siena, 6-7 October 2016
EuResist participates in the organization of the second AMS event in Siena: hands-on training on querying clinical-genetic DBs.
Stockholm, 28-30 September 2016
EuResist participates in the 3rd regional annual event, co-organised by EuResist partner Prof. Sonnerborg.
Cologne, 29-30 April 2016
For registration and accommodation: Claudia.Mueller@med.uni-duesseldorf.de
Erbil, 24-29 February 2016
During the second mission of the KRG SHMS Project, the pilot monitoring system has been installed in 10 test centres in Erbil, Dohuk and Suleymania.
The EuResist Engine has been retrained to predict response after 48 weeks from treatmennt start, on a database of more than 66.000 patients. Performance is 0.73 - 0.76 AUC